Soluble Guanylate Cyclase Stimulators in Heart Failure

被引：12

作者：

Kansakar, Sajog ^{[1
]}

Guragain, Ashish ^{[1
]}

Verma, Deepak ^{[2
]}

Sharma, Prabhat ^{[1
,3
]}

Dhungana, Bibek ^{[4
]}

Bhattarai, Bidit ^{[5
]}

Yadav, Sunil ^{[6
]}

Gautam, Ishant ^{[7
]}

机构：

[1] Manipal Coll Med Sci, Internal Med, Pokhara, Nepal

[2] Calif Inst Behav Neurosci & Psychol, Internal Med Family Med, Fairfield, CA USA

[3] Shankarapur Hosp, Internal Med, Kathmandu, Nepal

[4] KIST Med Coll, Internal Med, Lalitpur, Nepal

[5] Venus Hosp, Internal Med, Kathmandu, Nepal

[6] Topa Primary Hlth Ctr, Internal Med, Rajbiraj, Nepal

[7] Bhaktapur Hosp, Internal Med, Bhaktapur, Nepal

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2021年 / 13卷 / 09期

关键词：

heart failure with reduced ejection fraction (hfref); heart failure with preserved ejection fraction (hfpef); heart failure; guanylate cyclase stimulators; vericiguat; PRESERVED EJECTION FRACTION; NITRIC-OXIDE; VERICIGUAT; PATHOPHYSIOLOGY; CAPACITY; PLACEBO;

D O I：

10.7759/cureus.17781

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heart failure has a high global burden of morbidity and mortality. Despite significant advances in medical management of heart failure, the prognosis remains poor. This justifies the search for newer therapeutic agents. Recently, soluble guanylate stimulators have demonstrated favorable results in clinical trials. This article aims to summarize the guanylate cyclase signaling pathway, the role of soluble guanylate cyclase stimulators in heart failure, and data from recent clinical trials of these drugs. We concluded that soluble guanylate cyclase stimulators have significant benefits in reducing hospitalizations in patients with heart failure with reduced ejection fraction that are at high risk of cardiovascular events. There appears to be no benefit of these drugs in patients with heart failure with preserved ejection fraction.

引用

页数：7

共 50 条

[1] Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure
Liang, Wei-Lin
Liang, Bo
CURRENT CARDIOLOGY REPORTS, 2023, 25 (06) : 607 - 613
[2] Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure
Wei-Lin Liang
Bo Liang
Current Cardiology Reports, 2023, 25 : 607 - 613
[3] Efficacy and safety of soluble guanylate cyclase stimulators in patients with heart failure: A systematic review and meta-analysis
LI, Qi
LI, Zhuqing
LI, Tingting
Wang, Yanxin
Feng, Jiaxin
Lu, Chengzhi
PHARMAZIE, 2021, 76 (10): : 488 - 493
[4] The efficacy and safety of soluble guanylate cyclase stimulators in patients with heart failure A systematic review and meta-analysis
Zheng, Xiaoyu
Zheng, Weijin
Xiong, Bo
Huang, Jing
MEDICINE, 2018, 97 (41)
[5] Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials
Moghaddam, Nima
Malhi, Navraj
Toma, Mustafa
AMERICAN HEART JOURNAL, 2021, 241 : 74 - 82
[6] Vericiguat - soluble guanylate cyclase stimulator, in therapy of heart failure
Melenovsky, Vojtech
COR ET VASA, 2022, 64 (03) : 316 - 319
[7] Vericiguat: A Novel Soluble Guanylate Cyclase Stimulator for Use in Patients With Heart Failure
Gupta, Rahul
Lin, Muling
Maitz, Theresa
Egeler, David J. J.
Sood, Aayaan
Aronow, Wilbert S. S.
Rajeswaran, Yasotha
Ahnert, Amy M. M.
Vyas, Apurva V. V.
Frishman, William H. H.
Lanier, Gregg M. M.
CARDIOLOGY IN REVIEW, 2023, 31 (02) : 87 - 92
[8] Exploring New Cardiovascular Pathways Are Soluble Guanylate Cyclase Stimulators the Right Direction?
Michalak, Marek
Armstrong, Paul W.
CIRCULATION-HEART FAILURE, 2018, 11 (03)
[9] Vericiguat: A Novel Oral Soluble Guanylate Cyclase Stimulator for the Treatment of Heart Failure
Campbell, Nicole
Kalabalik-Hoganson, Julie
Frey, Kathleen
ANNALS OF PHARMACOTHERAPY, 2022, 56 (05) : 600 - 608
[10] Soluble guanylate cyclase stimulators for heart failure: a network meta-analysis and subgroup analyses of reduced and preserved ejection fraction
Abuelazm, Mohamed T.
Attia, Abdelrahman
Abdelnabi, Mohamed
Jafar, Uzair
Almaadawy, Omar
Elzeftawy, Mohamed A.
Mahmoud, Abdelrahman
Albakri, Khaled
Abdelazeem, Basel
EGYPTIAN HEART JOURNAL, 2024, 76 (01)

← 1 2 3 4 5 →